9 July 2025 - The threat of global 200 per cent tariffs on pharmaceutical products presents a challenge to Australia’s drug subsidy scheme after foreign lobbyists pushed for it to be leveraged in trade negotiations.
The tariff threats follow aggressive lobbying by the US pharmaceutical industry explicitly targeting Australia’s PBS – with pharmaceutical giants hoping to “leverage ongoing trade negotiations” against the PBS.